ACHIEVE LIFE SCIENCES, INC.
Datakwaliteit: 83%
ACHV
Nasdaq
Manufacturing
Chemicals
€ 3,28
▲
€ 0,02
(0,61%)
Marktkapitalisatie: 174,63 M
Prijs
€ 3,28
Marktkapitalisatie
174,63 M
Dagbereik
€ 3,20 — € 3,30
52-Weeksbereik
€ 1,95 — € 6,03
Volume
230.373
Openen € 3,21
50D / 200D Gem.
€ 4,09
19,79% below
50D / 200D Gem.
€ 3,81
13,81% below
Quick Summary
Belangrijkste Punten
Negative free cash flow of -49,47 M
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-145,18%
Onder sectorgemiddelde (-53,41%)
ROICN/A
Net MarginN/A
Op. MarginN/A
Veiligheid
Debt / Equity
N/A
Current Ratio5,14
Interest CoverageN/A
Waardering
PE (TTM)
-3,20
Onder sectorgemiddelde (-1,48)
P/B Ratio5,19
EV/EBITDAN/A
Dividend YieldN/A
Koershistorie
Financiële Trends
Sectorvergelijking
vs Manufacturing sector mediaan (1364 peers)
Sectorvergelijking
vs Manufacturing sector mediaan (1364 peers)| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -3,2 | -1,5 |
| P/B | 5,2 | 1,6 |
| ROE % | -145,2 | -53,4 |
| Net Margin % | — | -41,5 |
| Rev Growth 5Y % | — | 1,8 |
| D/E | — | 0,3 |
ETFs Holding This Stock
5,40% weight
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | N/A | Net Income (TTM) | -54,65 M |
| ROE | -145,18% | ROA | -98,49% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -49,47 M |
| ROIC | N/A | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 5,14 |
| Interest Coverage | N/A | Asset Turnover | N/A |
| Working Capital | 40,33 M | Tangible Book Value | 31,77 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -3,20 | Forward P/E | N/A |
| P/B Ratio | 5,19 | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -28,33% | ||
| Market Cap | 174,63 M | Enterprise Value | 142,70 M |
| Per Share | |||
| EPS (Diluted TTM) | -1,25 | Revenue / Share | N/A |
| FCF / Share | -0,93 | OCF / Share | -0,93 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 90,52% |
| SBC-Adj. FCF | -58,27 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Net Income | -54,65 M | -39,83 M | -29,82 M | -42,35 M | -33,15 M |
| EPS (Diluted) | -1,25 | -1,24 | -1,50 | -4,00 | — |
| Gross Profit | — | — | — | — | — |
| Operating Income | — | — | — | — | — |
| EBITDA | — | — | — | — | — |
| R&D Expenses | — | 22,82 M | 15,81 M | 30,08 M | 23,97 M |
| SG&A Expenses | — | — | — | — | — |
| D&A | 228.000,0 | 229.000,0 | 228.000,0 | 236.000,0 | — |
| Interest Expense | 819.000,0 | 2,18 M | 2,85 M | 1,79 M | — |
| Income Tax | — | — | — | — | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 41,79 M | 38,63 M | 19,37 M | 29,97 M | 47,52 M |
| Total Liabilities | 20,27 M | 17,73 M | 20,82 M | 21,67 M | 19,47 M |
| Shareholders' Equity | 21,52 M | 20,90 M | -1,45 M | 8,30 M | 28,04 M |
| Total Debt | — | — | — | — | — |
| Cash & Equivalents | 20,93 M | 12,75 M | 15,55 M | 24,77 M | 43,02 M |
| Current Assets | 39,89 M | 36,47 M | 16,98 M | 27,33 M | 44,59 M |
| Current Liabilities | 9,08 M | 6,68 M | 20,81 M | 21,60 M | 4,55 M |
{"event":"ticker_viewed","properties":{"ticker":"ACHV","listing_kind":"stock","pathname":"/stocks/achv","exchange":"Nasdaq","country":"US"}}